DT Investment Partners LLC Purchases 323 Shares of The Procter & Gamble Company (NYSE:PG)

DT Investment Partners LLC raised its position in The Procter & Gamble Company (NYSE:PGFree Report) by 1.4% during the fourth quarter, according to its most recent 13F filing with the SEC. The fund owned 22,858 shares of the company’s stock after buying an additional 323 shares during the period. DT Investment Partners LLC’s holdings in Procter & Gamble were worth $3,600,000 as of its most recent filing with the SEC.

A number of other hedge funds have also recently bought and sold shares of the company. Emerald Advisors LLC raised its holdings in shares of Procter & Gamble by 1.8% during the fourth quarter. Emerald Advisors LLC now owns 3,775 shares of the company’s stock valued at $553,000 after purchasing an additional 65 shares during the last quarter. O Brien Wealth Partners LLC raised its holdings in shares of Procter & Gamble by 3.3% during the fourth quarter. O Brien Wealth Partners LLC now owns 2,062 shares of the company’s stock valued at $302,000 after purchasing an additional 65 shares during the last quarter. KFA Private Wealth Group LLC raised its holdings in shares of Procter & Gamble by 2.2% during the third quarter. KFA Private Wealth Group LLC now owns 3,054 shares of the company’s stock valued at $445,000 after purchasing an additional 67 shares during the last quarter. Chemistry Wealth Management LLC raised its holdings in shares of Procter & Gamble by 1.2% during the fourth quarter. Chemistry Wealth Management LLC now owns 5,839 shares of the company’s stock valued at $856,000 after purchasing an additional 67 shares during the last quarter. Finally, Schear Investment Advisers LLC raised its holdings in shares of Procter & Gamble by 1.4% during the fourth quarter. Schear Investment Advisers LLC now owns 4,933 shares of the company’s stock valued at $723,000 after purchasing an additional 67 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors.

Procter & Gamble Price Performance

PG traded up $0.85 during trading on Friday, hitting $158.14. 12,034,186 shares of the company traded hands, compared to its average volume of 6,329,782. The company has a market cap of $372.11 billion, a PE ratio of 26.47, a P/E/G ratio of 3.22 and a beta of 0.44. The stock’s 50-day simple moving average is $159.14 and its two-hundred day simple moving average is $152.92. The Procter & Gamble Company has a 1 year low of $141.45 and a 1 year high of $163.14. The company has a current ratio of 0.64, a quick ratio of 0.44 and a debt-to-equity ratio of 0.48.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Friday, April 19th. The company reported $1.52 EPS for the quarter, topping analysts’ consensus estimates of $1.42 by $0.10. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. The business had revenue of $20.20 billion during the quarter, compared to analysts’ expectations of $20.43 billion. During the same period last year, the company posted $1.37 EPS. The business’s revenue was up .6% on a year-over-year basis. As a group, sell-side analysts anticipate that The Procter & Gamble Company will post 6.45 earnings per share for the current fiscal year.

Procter & Gamble Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Friday, April 19th will be issued a $1.0065 dividend. This represents a $4.03 annualized dividend and a dividend yield of 2.55%. The ex-dividend date of this dividend is Thursday, April 18th. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.94. Procter & Gamble’s dividend payout ratio (DPR) is 67.50%.

Insider Transactions at Procter & Gamble

In other news, CEO R. Alexandra Keith sold 776 shares of the firm’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total value of $122,693.36. Following the completion of the sale, the chief executive officer now owns 4,859 shares in the company, valued at approximately $768,256.49. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the sale, the chief executive officer now owns 4,859 shares in the company, valued at approximately $768,256.49. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Gary A. Coombe sold 22,000 shares of the business’s stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the completion of the sale, the chief executive officer now owns 36,845 shares of the company’s stock, valued at approximately $5,943,835.40. The disclosure for this sale can be found here. In the last quarter, insiders sold 279,063 shares of company stock worth $43,187,745. 0.17% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the stock. Truist Financial upgraded shares of Procter & Gamble from a “hold” rating to a “buy” rating and increased their price target for the stock from $160.00 to $175.00 in a research report on Monday, March 11th. Wells Fargo & Company increased their price target on shares of Procter & Gamble from $162.00 to $170.00 and gave the stock an “overweight” rating in a research report on Wednesday, January 24th. The Goldman Sachs Group assumed coverage on shares of Procter & Gamble in a research report on Friday, March 1st. They issued a “neutral” rating and a $168.00 price target on the stock. Stifel Nicolaus increased their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the stock a “hold” rating in a research report on Wednesday, January 24th. Finally, Deutsche Bank Aktiengesellschaft increased their price target on shares of Procter & Gamble from $170.00 to $172.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Seven analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and an average target price of $168.53.

Check Out Our Latest Stock Report on Procter & Gamble

Procter & Gamble Company Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.